Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication

Published:2018-10-16 Issue:5 Volume:111 Page:484-489
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Cheung Ka Shing¹,Chan Esther W²,Wong Angel Y S²³,Chen Lijia¹,Seto Wai Kay¹,Wong Ian C K²⁴,Leung Wai K¹

Affiliation:

1. Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong

2. Department of Pharmacology and Pharmacy, Centre for Safe Medication Practice and Research, The University of Hong Kong, Hong Kong

3. Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK

4. UCL School of Pharmacy, University College London, London, UK

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/111/5/484/28580404/djy144.pdf

Reference46 articles.

1. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts;Gut.,2001

2. Association between helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis;Lee;Gastroenterology,2016

3. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials;Ford;BMJ.,2014

4. Risk of gastric cancer development after eradication of Helicobacter pylori;Cheung;World J Gastrointest Oncol.,2018

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin suppresses gastric cancer progression by disrupting the STAT1-PRMT1 axis;Biochemical Pharmacology;2024-08

2. Revealing the role of metformin in gastric intestinal metaplasia treatment;Frontiers in Pharmacology;2024-07-19

3. Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study;Gastric Cancer;2024-06-10

4. Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism;Scientific Reports;2024-05-30

5. Metformin: A Dual-Role Player in Cancer Treatment and Prevention;International Journal of Molecular Sciences;2024-04-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3